-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
3,4-Di(3-indolyl)-1H-pyrrole-2,5-dione
Category | Cytomegalovirus (CMV) |
CAS | 119139-23-0 |
Description | Bisindolylmaleimide IV (BIM IV) is an inhibitor of pyruvate phosphate dikinase (PPDK). It is a cell-permeable potent and somewhat selective inhibitor of PKC with IC50 of 87 nM. BIM IV is a cell-permeable inhibitor of protein kinase C (PKC) with IC50 values reported to range from 0.10 to 0.55 µM. It also inhibits protein kinase A (PKA) with an IC50 of 2.7 μM. |
Product Information
Synonyms | 3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione; 3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione |
IUPAC Name | 3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione |
Molecular Weight | 327.34 |
Molecular Formula | C20H13N3O2 |
Canonical SMILES | C1=CC=C2C(=C1)C(=CN2)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54 |
InChI | InChI=1S/C20H13N3O2/c24-19-17(13-9-21-15-7-3-1-5-11(13)15)18(20(25)23-19)14-10-22-16-8-4-2-6-12(14)16/h1-10,21-22H,(H,23,24,25) |
InChIKey | DQYBRTASHMYDJG-UHFFFAOYSA-N |
Boiling Point | 690.1 °C at 760 mmHg (Predicted) |
Melting Point | 296.19 °C (Predicted) |
Flash Point | 371.2±31.5 °C |
Purity | > 98 % |
Density | 1.486 g/cm3 |
Solubility | Soluble in DMSO. |
Appearance | Crystalline solid |
Storage | Powder: -20°C 3 years 4°C 2 years In solvent: -80°C 6 months -20°C 1 months |
Complexity | 576 |
Exact Mass | 327.100776666 |
Index Of Refraction | 1.811 |
In Vitro | The IC50 of biindolecarboximide IV (Arcyriarubin A) in 1% dimethyl sulfoxide is 0.1 μM and the IC50 in 10% dimethyl sulfoxide is 0.55 μM, which has an inhibitory effect on PKC. |
PSA | 77.75000 |
Target | PKC; CMV |
Vapor Pressure | 0.0±2.2 mmHg at 25°C |
XLogP3-AA | 2.8 |